Group 1 - The report from CMB International indicates that the Chinese stock market is rising, with the Hong Kong sectors of healthcare, information technology, and industrials leading the gains, while materials, consumer staples, and telecommunications lag behind [1] - Southbound net purchases amounted to HKD 1.48 billion, with WuXi Biologics (02269), Xiaomi Group-W (01810), and Xpeng Motors-W (09868) seeing the highest net inflows [1] - In the A-share market, semiconductor, defense, and machinery sectors showed the largest gains, while consumer services, daily consumer retail, and discretionary consumer retail experienced the most significant declines [1] Group 2 - The US stock market has seen a continuous rebound, with industrials, information technology, and communication services leading the increases, while consumer staples, healthcare, and discretionary consumer sectors have declined [1] - Recent US unemployment data does not affect the expectations for interest rate cuts this month, and ahead of the significant PCE inflation data release, the upward momentum in the US stock market has diminished, with the chip index halting its two-day rise [1] - Notably, NVIDIA (NVDA.US) has shown positive guidance, while Salesforce (CRM.US) increased by nearly 4% [1] Group 3 - Microsoft (MSFT.US) announced a price increase for its Office software targeted at business and government clients, with some enterprise packages seeing price hikes of over 10% starting July 1 next year [1]

Core Viewpoint - Morgan Stanley's report indicates a significant rebound in the stock prices of China's CXO (Contract Research Organization) industry, including WuXi AppTec, WuXi AppTec Holding, and WuXi Biologics, following a period of weak performance due to market concerns over a potentially lenient version of the "Biological Safety Act" being passed alongside the ongoing revisions of the "2026 National Defense Authorization Act" in the U.S. Congress [1] Group 1 - The stock prices of WuXi AppTec, WuXi AppTec Holding, and WuXi Biologics have recently rebounded significantly [1] - Earlier weak performance of these stocks was attributed to market fears regarding the legislative changes in the U.S. [1] - The recent price rebound may reflect a alleviation of these concerns, although there has been no update on the National Defense Authorization Act [1] Group 2 - Morgan Stanley believes that the geopolitical tensions between China and the U.S. will continue to ease, which is favorable for the development of China's CXO industry [1] - The target prices set by Morgan Stanley are as follows: WuXi AppTec at HKD 74, WuXi AppTec Holding at HKD 142, and WuXi Biologics at HKD 37, all rated as "Overweight" [1]

Group 1 - The number of initial jobless claims in the U.S. unexpectedly dropped to a three-year low, contrasting sharply with earlier weak ADP employment reports and record corporate layoffs, leading to a divergence in market perceptions regarding a soft landing for the U.S. economy [2] - The interest rate futures market is increasingly betting that the Federal Reserve will ignore data noise and implement rate cuts, indicating a significant shift in macroeconomic logic where investors believe the Fed's policy response has transitioned from being data-dependent to a more preemptive easing approach to mitigate potential economic slowdown risks [2] Group 2 - On Thursday, the Hong Kong Stock Connect saw a net inflow of HKD 1.5 billion, with the largest net inflow into the Tracker Fund of Hong Kong (02800.HK) amounting to HKD 2.61 billion, followed by WuXi Biologics (02269.HK) [2] - Conversely, Tencent Holdings (00700.HK) experienced the largest net outflow, totaling HKD 1.35 billion, followed by Semiconductor Manufacturing International Corporation (00981.HK) [2]

每日晨报│2025 年 12 月 5 日 主要市场指数表现 | | 收市价 | 上个交易日升 | YTD 升跌 | | --- | --- | --- | --- | | 恒生指数 | 25,935 | +0.68% | +29.29% | | 恒生科技指数 | 5,615 | +1.45% | +25.68% | | 国企指数 | 9,106 | +0.86% | +24.92% | | 沪深 300 | 4,546 | +0.34% | +15.54% | | 上证综合指数 | 3,875 | -0.06% | +15.63% | | 深证成份指数 | 13,006 | +0.40% | +24.89% | | 中小板指 | 7,904 | +0.26% | +23.85% | | 道琼斯指数 | 47,850 | -0.07% | +12.47% | | 标普 500 指数 | 6,857 | +0.11% | +16.59% | | 纳斯达克指数 | 23,505 | +0.22% | +21.72% | | 伦敦富时指数 | 9,710 | +0.19% | +18.82% | | CAC40 指数 ...

Industry Overview - The wide bandgap semiconductor industry, driven by Silicon Carbide (SiC) and Gallium Nitride (GaN), is entering a new phase of sustained growth, primarily fueled by the electrification of vehicles and the restructuring of power architecture in AI data centers [2][3] - The industry is transitioning from traditional 54V DC power supply to 800V High Voltage Direct Current (HVDC) architecture, which is crucial for the next generation of high-power AI racks, relying heavily on the application of SiC and GaN [2][7] Market Growth - According to TrendForce, the global SiC power device market is expected to reach approximately $3.4 billion in 2024, representing a year-on-year growth of 12%, with automotive applications accounting for over 70% of this market [3] - The GaN device market is projected to grow by 43% year-on-year, reaching about $388 million, with continued expansion expected due to increasing penetration in automotive and renewable energy sectors, as well as emerging applications in AI data centers [3] Investment Opportunities - Companies with scale advantages, leading technology on 8-inch wafers, automotive-grade certified product lines, and system-level solution capabilities are expected to be the main beneficiaries of this trend [2] - In particular, InnoPhase (2577 HK) is highlighted as a leading player in the pure GaN sector, with an anticipated market share of around 30% in 2024 and a projected compound annual growth rate (CAGR) of approximately 55.2% from 2024 to 2027, benefiting from industry tailwinds and strategic partnerships with global players like NVIDIA [7]

2025 年 12 月 5 日 星期五 宏观动态： 美国上周首次申请失业救济人数 19.1 万人，低于市场预期的 22 万人，及前周的 21.8 万人。 ➢ 每日大市点评 行业动态： 昨日港股大市高开后一度调整，但是其后再次获得支持。恒生指数及国企指数分别收报 25,936 点及 9,106 点，上升 0.7% 及 0.9%。港股成交合共 1,793 亿港元，较前日的 1,644 亿港元，上升 9.1%，可反映投资意欲仍然较高。分类指数方面， 医疗保健及信息科技业指数分别上升 2.1%及 1.4%；原材料及必需性消费则分别下跌 0.2%及 0.01%。蓝筹个股方面，药明 生物(2269 HK)及药明康德(2359 HK)领涨，分别上升 7.1%及 5.4%；申洲国际(2313 HK)及金沙中国(1928 HK)领跌，分别 下跌 4.7%及 1.6%。 昨日半导体板块表现较好。芯智控股(2166 HK)、宏光半导体(6908 HK)、中芯国际(981 HK)上涨 3.9%-4.3%。消息面上， 市场传闻寒武纪(688256 CH)计划在 2026 年将其 AI 芯片产量提高两倍以上，目标填补英伟达(NVDA U ...

大消费走势低迷，截至目前下跌1.01%。其中小鹏汽车下跌3.62%，名创优品、巨子生物、农夫山泉等 近10只个股跌幅在2%上方。 内容只是个人观点，仅供参考，不作为投资依据！欢迎关注交流，互相学习、共同探讨！ 互联网低开低走后一路回撤，截止午盘大跌1.32%，其中网易大跌3.3%，地平线机器人下跌2.88%，哔 哩哔哩下跌2.7%，阿里巴巴、快手、商汤、腾讯控股等股跌幅均在1%上方。 恒生医疗开盘后直线跳水，随后一路回撤，截至目前下跌1.23%。其中三生制药下跌2.91%，中国生物 下跌2.17%，信达生物下跌2.08%，百济神州、京东健康、药明生物、石药集团等超10只个股跌幅均在 1%上方。 低开低走陷入调整，截至收盘恒生指数下跌0.97%。互联网跌幅居前，大消费、恒生科技、恒生医疗、 银行等紧随其后。 ...

Core Viewpoint - The market experienced a rebound with the Hang Seng Index closing up by 0.68%, driven primarily by gains in the healthcare sector, followed by technology, internet, and consumer sectors, while banks remained relatively weak [1]. Group 1: Healthcare Sector - The Hang Seng Healthcare index opened high and surged, closing up by 1.74%. Notable performers included WuXi Biologics, which rose by 7.09%, WuXi AppTec up by 5.44%, and CanSino Biologics increasing by 4.4%. Other companies like China Biologic Products, Innovent Biologics, and BeiGene also saw gains exceeding 1% [3]. Group 2: Technology Sector - The Hang Seng Technology index rebounded and closed up by 1.21%. Key stocks included Xiaomi Group, which increased by 4.38%, SMIC up by 3.87%, and Meituan rising by 2.29%. Other major players like Baidu, Alibaba, and JD.com also recorded slight increases [3]. Group 3: Banking Sector - The banking sector showed signs of recovery but remained weak, closing up by 0.27%. Notable increases were seen in China Merchants Bank, which rose by 1.84%, Zhengzhou Bank up by 1.65%, and Agricultural Bank of China increasing by 1.04%. However, Standard Chartered Bank experienced a decline of 1.09% [3].

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年11月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: WuXi Biologics (Cayman) Inc. 藥明生物技術有限公司*（於開曼群島註冊成立的有限公司）*僅供識別 呈交日期: 2025年12月4日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02269 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 6,000,000,000 | USD | 0.000008333333 | USD | | 50,000 | | 增加 / 減少 (-) | | | 0 | | | USD | | 0 | | 本月底結存 | | | 6,000,000,000 | ...

Core Insights - On December 4, 2023, Sanhua Intelligent Control made its debut on the Hong Kong Stock Connect active trading list for the first time in a month, with a trading volume of 0.853 billion HKD and a net sell of 0.057 billion HKD, closing up by 7.70% [1] Trading Activity Summary - The total trading volume of active stocks on the Hong Kong Stock Connect on December 4 was 28.218 billion HKD, accounting for 37.28% of the day's total trading amount, with a net buying amount of 1.402 billion HKD [1] - Alibaba-W led the trading volume with 5.318 billion HKD, followed by Tencent Holdings and Xiaomi Group-W with trading amounts of 5.271 billion HKD and 4.995 billion HKD, respectively [1] - The most frequently listed stocks in the past month were Alibaba-W and Tencent Holdings, each appearing 22 times, indicating strong interest from Hong Kong Stock Connect investors [1] Individual Stock Performance - Sanhua Intelligent Control's trading details on December 4 included a trading volume of 0.853 billion HKD, a net sell of 0.057 billion HKD, and a closing price of 34.960 HKD, reflecting a daily increase of 7.70% [1] - Other notable stocks included: - Tencent Holdings: Trading volume of 5.271 billion HKD, net sell of 1.346 billion HKD, closing price of 612.000 HKD, daily increase of 0.16% [1] - Xiaomi Group-W: Trading volume of 4.995 billion HKD, net buy of 0.232 billion HKD, closing price of 41.980 HKD, daily increase of 4.38% [1] - Alibaba-W: Trading volume of 5.318 billion HKD, net sell of 0.010 billion HKD, closing price of 154.400 HKD, daily increase of 0.52% [1]